Obs Gyne Review: Journal of Obstetric and Gynecology https://obstetrics.medresearch.in/index.php/joog <div id="journalDescription-8" class="journalDescription"> <p><em><strong>ISSN: <a href="https://portal.issn.org/resource/ISSN/2455-5444" target="_blank" rel="noopener">2455-5444 (Online)</a>, <a href="https://portal.issn.org/resource/ISSN/2581-4389" target="_blank" rel="noopener">2581-4389 (Print)</a></strong></em></p> <p><em><strong>RNI: MPENG/2017/74037</strong></em></p> </div> Siddharth Health Research and Social Welfare Society en-US Obs Gyne Review: Journal of Obstetric and Gynecology 2581-4389 The effect of prophylactic use of intravenous tranexamic acid in abdominal hysterectomy https://obstetrics.medresearch.in/index.php/joog/article/view/128 <p>Introduction: Hysterectomy is one of the frequently performed major gynecological surgical procedures for various uterine pathologies. The objective of this study is to assess the effect of intravenous tranexamic acid in reducing intraoperative and postoperative blood loss in women undergoing abdominal hysterectomy.</p> <p>Materials and Methods: The study was a randomized double-blind study, involving a total of 120 women undergoing abdominal hysterectomy for benign etiology were randomly assigned to two groups: Group 1 (non TA): (n=60) women receiving normal saline and Group 2 (TA): (n=60) women receiving prophylactic Tranexamic Acid in 100 ml saline IV just before skin incision. The primary outcome was intraoperative, postoperative, and all blood loss estimation.</p> <p>Results: Group 2 (TA) showed a great reduction in intraoperative and postoperative blood loss (blood in the intra-abdominal drain) compared with Group 1 (non TA), (P = 0.0001, 0.0001), so the overall estimated blood loss in groups 2 showed significant reduction compared with Group 1 (P = 0.0001).</p> <p>Conclusion: Intravenous tranexamic acid is a safe and reliable method to help decrease blood loss during and after abdominal hysterectomy.</p> Dr. Smita Barya Dr. Sameer Goyal Copyright (c) 2021 Author (s). Published by Siddharth Health Research and Social Welfare Society https://creativecommons.org/licenses/by/4.0 2021-02-28 2021-02-28 7 1 01 05 10.17511/joog.2021.i01.01 Antibiograms of uropathogens in obstetric patients https://obstetrics.medresearch.in/index.php/joog/article/view/129 <p>Background: Urinary tract infections (UTI) are the most commonly encountered infections in obstetric patients.</p> <p>Aim: The current study was undertaken to find the spectrum of micro-organisms responsible for causing UTI in obstetric patients and to find out the most appropriate antibiotic.</p> <p>Materials and Methods: Consecutive patients in different stages of pregnancy with or without symptoms of UTI attending the antenatal clinic from June 2019 to November 2020 were screened for significant bacteriuria. The bacterial uropathogens isolated were then subjected to antimicrobial susceptibility testing and screened for ESBL production and methicillin resistance.</p> <p>Results: During the 18-month study period, out of the 110 samples screened, a total of 66 (60%) samples of urine from pregnant females, in different stages of pregnancy were found to be positive on culture. The Enterobacteriaceae accounted for nearly 69.69% of the isolates and E. coli alone accounted for 42.42% of the urinary isolates followed by Acinetobacter 19.69%. Among the Gram-positive cocci, Enterococcus 25.75% were more frequently isolated than Staphylococcus aureus (4.54%). Significantly high resistance was noted to the beta-lactam group of antimicrobials, fluoroquinolones and cotrimoxazole, both by the Gram-negative bacilli as well as Gram-positive cocci. Resistance was quite low against the aminoglycosides and nitrofurantoin and virtually absent against imipenem.</p> <p>Conclusion: The susceptibility patterns seen in our study seem to suggest that it is necessary to obtain sensitivity reports before initiation of antibiotic therapy in cases of suspected UTI.</p> Dr. Monika Jindal Dr. Shrikrishna Kumar Agrawal Dr. Anju Pungale Copyright (c) 2021 Author (s). Published by Siddharth Health Research and Social Welfare Society https://creativecommons.org/licenses/by/4.0 2021-02-28 2021-02-28 7 1 06 12 10.17511/joog.2021.i01.02 A study of Maternal BMI as Determinant of Pregnancy & Perinatal Outcomes in Hazaribagh Medical College and Hospital, Hazaribagh. https://obstetrics.medresearch.in/index.php/joog/article/view/131 <p>Introduction: Maternal nutrition plays an important role in maternal and fetal outcomes. The low maternal BMI or Obesity are both associated with adverse outcomes.</p> <p>Objectives: To evaluate the impact of the maternal body mass index on the pregnancy outcome and neonatal outcomes.</p> <p>Materials and Methods: This is a prospective cohort study in which a total of 200 patients meeting the inclusion criteria were enrolled in the study after informed consent of which 100 patients enrolled after 18 weeks of gestation had a low BMI and 100 patients with a higher BMI than normal.</p> <p>Results: Pregnant females having low BMI as baseline had more risk of IUGR, fetal distress and low birth weight in newborns while those having high maternal BMI had more incidence of PIH in mothers, oligohydramnios, increased birth weight, increased risk of LSCS and NICU admissions and delayed maternal wound healing.</p> <p>Conclusion: The health of women, throughout their childbearing ages, should be cared , to improve their obstetrical and perinatal outcomes. Also, the high-risk groups should be managed properly.</p> Dr. Snehlata Dr. Sweta Lal Copyright (c) 2021 Author (s). Published by Siddharth Health Research and Social Welfare Society https://creativecommons.org/licenses/by/4.0 2021-03-13 2021-03-13 7 1 13 20 10.17511/joog.2021.i01.03